CD274 and neoplasm: This synergistic effect is thought to be due to chemotherapy activating an endogenous antitumor immune response, causing the enhancement of co-stimulatory molecules like CD80 and CD86 and the downregulation of PD-L1, and inducing immunogenic tumor cell death [62].